Market closed
Genprex Inc./$GNPX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Genprex Inc.
Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.
Ticker
$GNPX
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
15
Website
Genprex Inc. Metrics
BasicAdvanced
$6.4M
-
-$5.34
-0.39
-
Price and volume
Market cap
$6.4M
Beta
-0.39
52-week high
$0.52
52-week low
$0.22
Average daily volume
6.9M
Financial strength
Current ratio
0.83
Quick ratio
0.64
Management effectiveness
Return on assets (TTM)
-178.90%
Return on equity (TTM)
-473.37%
Valuation
Price to book
1.77
Price to tangible book (TTM)
1.77
Price to free cash flow (TTM)
-0.062
Growth
Earnings per share change (TTM)
-76.34%
3-year earnings per share growth (CAGR)
-32.75%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Genprex Inc. stock?
Genprex Inc. (GNPX) has a market cap of $6.4M as of April 16, 2025.
What is the P/E ratio for Genprex Inc. stock?
The price to earnings (P/E) ratio for Genprex Inc. (GNPX) stock is 0 as of April 16, 2025.
Does Genprex Inc. stock pay dividends?
No, Genprex Inc. (GNPX) stock does not pay dividends to its shareholders as of April 16, 2025.
When is the next Genprex Inc. dividend payment date?
Genprex Inc. (GNPX) stock does not pay dividends to its shareholders.
What is the beta indicator for Genprex Inc.?
Genprex Inc. (GNPX) has a beta rating of -0.39. This means that it has an inverse relation to market volatility.